Cargando…
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation
BACKGROUND: TMEM199 deficiency was recently shown in four patients to cause liver disease with steatosis, elevated serum transaminases, cholesterol and alkaline phosphatase and abnormal protein glycosylation. There is no information on the long-term outcome in this disorder. RESULTS: We here present...
Autores principales: | Vajro, Pietro, Zielinska, Katarzyna, Ng, Bobby G., Maccarana, Marco, Bengtson, Per, Poeta, Marco, Mandato, Claudia, D’Acunto, Elisa, Freeze, Hudson H., Eklund, Erik A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763540/ https://www.ncbi.nlm.nih.gov/pubmed/29321044 http://dx.doi.org/10.1186/s13023-017-0757-3 |
Ejemplares similares
-
CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking
por: Wilson, Matthew P, et al.
Publicado: (2022) -
The Swedish COG6‐CDG experience and a comprehensive literature review
por: Xia, Zhi‐Jie, et al.
Publicado: (2022) -
TMEM199-Congenital Disorder of Glycosylation With Novel Phenotype and Genotype in a Chinese Boy
por: Fang, Yuan, et al.
Publicado: (2022) -
Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study
por: Witters, Peter, et al.
Publicado: (2021) -
Nutritional Therapies in Congenital Disorders of Glycosylation (CDG)
por: Witters, Peter, et al.
Publicado: (2017)